A. RecruitmentDevelopmental funds to support the recruitment of new investigators to the IUSCC will be critical in the nextfunding cycle to accomplish our strategic plan of the Center. During the current funding cycle, developmentalfunds were used to support the growth of research programs through targeted faculty recruitments.Investigators were recruited to all four IUSCC programs (Cancer Control, Hematopoiesis, Microenvironmentand Immunology, Breast Cancer, and Experimental and Developmental Therapeutics) to accomplish thestrategic objectives of the Center which had been identified as needing to increase our Gl, breast,epidemiology, lung cancer, and hematopoiesis faculty as well as cancer control members. Eighteen facultymembers were successfully recruited with primary appointments in eight departments. Of these, ten now holdpeer reviewed federal cancer research grants. All recruitment objectives discussed in the previous CCSGapplication were addressed (behavioral science and basic science focused on Gl and ovarian cancers).Future recruiting efforts in the upcoming grant cycle will be targeted toward expanding our Breast Cancer,Cancer Control and EOT Programs as well as the developing programs Molecular and EnvironmentalCarcinogenesis and Tumor Microenvironment, outlined in the IUSCC Strategic Plan. CCSG funds are often acritical component of the packages that we use to recruit top candidates and provide the Cancer CenterDirector with real input into the recruitment of top cancer investigators into the institution.B. Pilot Projects: Developmental funds are also pivotally important for support of pilot research projects.Until September 2006, the IUSCC allocated pilot project funds by internal review of applications responding tospecific RFA's. These RFA's could target a specific cancer type or research program. Some requiredcollaboration with members of the Purdue Cancer Center and were jointly funded by both Centers. Reviewcriteria included scientific relevance, collaboration and potential for future peer-reviewed funding. The IUSCCsupported nineteen such projects, which are shown in Table 1 later in this section. Traditional use of funds forpilot funding of IUSCC projects changed dramatically when in September 2006, IUSCC Senior Leaders begana new and innovative approach for the allocation of pilot research funds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082709-10
Application #
7698875
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-01
Project End
2013-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
10
Fiscal Year
2008
Total Cost
$95,828
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Robertson, Michael J; Stamatkin, Christopher W; Pelloso, David et al. (2018) A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma. J Immunother 41:151-157
Huang, Xinxin; Guo, Bin; Liu, Sheng et al. (2018) Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment. Nat Commun 9:2741
Serratore, Nina D; Baker, Kortany M; Macadlo, Lauren A et al. (2018) A Novel Sterol-Signaling Pathway Governs Azole Antifungal Drug Resistance and Hypoxic Gene Repression in Saccharomyces cerevisiae. Genetics 208:1037-1055
Hoggatt, Jonathan; Singh, Pratibha; Tate, Tiffany A et al. (2018) Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell. Cell 172:191-204.e10
Filley, Anna; Henriquez, Mario; Bhowmik, Tanmoy et al. (2018) Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas. J Neurooncol 137:469-479
Sishtla, Kamakshi; Pitt, Natalie; Shadmand, Mehdi et al. (2018) Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14. Sci Rep 8:16152
Koh, Byunghee; Abdul Qayum, Amina; Srivastava, Rajneesh et al. (2018) A conserved enhancer regulates Il9 expression in multiple lineages. Nat Commun 9:4803
Reese, Michael J; Knapp, Deborah W; Anderson, Kimberly M et al. (2018) In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs. PLoS One 13:e0203517
Singh, Pratibha; Fukuda, Seiji; Liu, Liqiong et al. (2018) Survivin Is Required for Mouse and Human Bone Marrow Mesenchymal Stromal Cell Function. Stem Cells 36:123-129
Olivos 3rd, David J; Perrien, Daniel S; Hooker, Adam et al. (2018) The proto-oncogene function of Mdm2 in bone. J Cell Biochem 119:8830-8840

Showing the most recent 10 out of 256 publications